“Lebrikizumab Provides Progressive Improvements in Skin Clearance and Itch Relief Over One Year in Patients with Atopic Dermatitis” (2023) SKIN The Journal of Cutaneous Medicine, 7(6), p. s278. doi:10.25251/skin.7.supp.278.